跳至主要内容
临床试验/NCT05086900
NCT05086900已完成不适用

Developing a Patient Reported Outcome Measure for Recurrent Urinary Tract Infection

University of Reading1 个研究点 分布在 1 个国家目标入组 283 人开始时间: 2021年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
283
试验地点
1
主要终点
Recurrent Urinary Tract Infection Symptom Scale

研究概览

简要总结

This study aims to develop and validate the first set of patient-reported outcome measures for recurrent urinary tract infection (UTI): the Recurrent UTI Symptom Scale and the Recurrent UTI Impact Questionnaire. These tools could be used in clinical practice, clinical trials and research to gather an insight into a patient's perspective of their recurrent UTI symptom severity and its impact on their life, as well as determining any possible improvement or other change in their condition due to interventions (e.g. antibiotic treatment).

详细描述

Urinary tract infection (UTI) is a highly prevalent infection, most frequently affecting females. Recurrent UTI, a chronic condition defined as experiencing two or more UTIs in six months or three or more in twelve months, is associated with significant symptom burden and lowered quality of life. In addition to this personal impact, the effects span more widely to issues such as increased healthcare costs, work absenteeism, and antimicrobial resistance.

There are currently no validated patient-reported outcome measures to assess recurrent UTI symptoms and impact. These measures are much needed to encourage a more patient-centred approach to recurrent UTI treatment and care, which could be especially important given evidence that current routine testing approaches, and thus treatment approaches, are not sufficient alone.

This mixed-methods study aims to consult both clinicians and patients in order to develop and validate the first set of patient-reported outcome measures for recurrent UTI.

Outline:

Phase I: Concept elicitation Conduct a literature review and examine the findings of an international qualitative study exploring the experience of over 2,000 people living with recurrent UTI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinicians (Phase III only):
  • Aged at least 18 years old.
  • Specialist doctor or nurse in the field of urology or a closely related discipline OR general health doctor or nurse.
  • Minimum of 3 years of direct experience treating patients with recurrent UTI.
  • Patients (Phases IV and V):
  • Aged at least 18 years old.
  • Experiences recurrent UTI as defined by the European Association of Urology: minimum of 2 UTIs in 6 months or minimum of 3 UTIs in 12 months.

排除标准

  • Current diagnosis of interstitial cystitis.
  • Non-fluent or non-advanced level of English.
  • Current pregnancy.
  • Current use of urinary catheterisation.

结局指标

主要结局

Recurrent Urinary Tract Infection Symptom Scale

时间窗: Time 2 (24 hours after baseline)

RUTISS; Total minimum score = 0, total maximum score = 170. Newly designed instrument that can measure the patient experience of recurrent UTI symptoms and pain and/or discomfort; Urinary symptoms sub-scale minimum score = 0, maximum score = 70; urinary pain sub-scale minimum score = 0, maximum score = 100; higher scores indicate higher symptom severity

Recurrent Urinary Tract Infection Impact Questionnaire

时间窗: Time 2 (24 hours after baseline)

RUTIIQ; Total minimum score = 0, maximum score = 300. Higher scores indicate higher rUTI impact and psychosocial burden. Newly designed instrument that can measure the patient experience of recurrent UTI impact on personal wellbeing, social activities, work and daily activities, sexual activity, and satisfaction with UTI-related medical care; personal wellbeing sub-scale minimum score = 0; maximum score = 40; social wellbeing sub-scale minimum score = 0, maximum score = 50; work/activity interference sub-scale minimum score = 0, maximum score = 70; sexual wellbeing sub-scale minimum score = 0, maximum score = 40; patient satisfaction sub-scale minimum score = 0, maximum score = 100. The sexual wellbeing subscale is optional and therefore fewer participants than the total number provided data for analysis.

次要结局

  • Depression(Time 2 (24 hours after baseline))
  • Urinary Tract Infection Symptom Assessment(Time 2 (24 hours after baseline))
  • Loneliness(Time 2 (24 hours after baseline))
  • Anxiety(Time 2 (24 hours after baseline))
  • Satisfaction with Treatment(Time 2 (24 hours after baseline))
  • Work Productivity and Impairment Questionnaire(Time 2 (24 hours after baseline))
  • Numerical Pain Rating Scale(Time 2 (24 hours after baseline))
  • Sexual Distress(Time 2 (24 hours after baseline))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katherine Finlay

Lecturer in Psychology

University of Reading

研究点 (1)

Loading locations...

相似试验